APA Handbook of Psychopharmacology

Suzette M. Evans, PhD, is a psychologist trained in biopsychology at The University of Chicago and in behavioral pharmacology at the Johns Hopkins University School of Medicine. She is currently a professor of clinical neurobiology (in psychiatry) at the Columbia University Vagelos College of Physicians and Surgeons and research scientist VI at the New York State Psychiatric Institute. She has been a member of the American Psychological Association (APA) and Division 28 (Psychopharmacology and Substance Abuse) since 992. She served as president of Division 28 in 2 7 and served as a member of the APA Board of Convention Affairs from 2 to 2 4. She is also a recent past editor of the APA journal Experimental and Clinical Psychopharmacology (2 amp ndash 2 7). Dr. Evans has more than publications and 3 years of research experience that span preclinical research with laboratory animals, human laboratory research, and clinical treatment research in substance abuse. Over the past 25 years Dr. Evans has received continuous research funding, primarily from the National Institute on Drug Abuse. Much of her research has used controlled laboratory procedures in humans to examine the acute behavioral and reinforcing effects of drugs of abuse, including alcohol, cannabis, and cocaine. Her focus is identifying potential behavioral and neurobiological markers of vulnerability to identify high-risk individuals before they transition from casual recreational use to problematic drug use. Several of these factors include stress, impulsivity, and decision making. Moreover, she has been at the forefront of exploring the role of sex as a biological variable. Much of her past and current research focuses on examining potential differences between males and females, including hormonal influences across the menstrual cycle.

• Editorial BoardAbout the Editor-in-ChiefContributorsA Note From the PublisherIntroductionPart I. Fundamental Principles of Pharmacology and PsychopharmacologyChapter . A Brief History of Psychopharmacology in the Context of Psychology and PsychiatryChapter 2. Basic Information on Psychotropic Drugs, Receptor Systems, and the BrainChapter 3. Basic PsychopharmacologyChapter 4. The Role of Animal Laboratory Research in PsychopharmacologyChapter 5. The Role of Clinical (Human) Laboratory Research in PsychopharmacologyChapter . Evidence-Based PharmacotherapyPart II. Implementing Psychopharmacology for the Treatment of Psychological Disorders, Substance Use Disorders, and AddictionSection . Pharmacological Treatment of Psychological DisordersChapter 7. Pharmacological Treatment of Depressive DisordersChapter 8. Pharmacological Treatment of Bipolar DisordersChapter 9. Pharmacological Treatment of Anxiety DisordersChapter . Pharmacological Treatment of Schizophrenia and Other Psychotic DisordersChapter . Pharmacological Treatment of Obsessive-Compulsive Disorder and Related DisordersChapter 2. Pharmacological Treatment of Impulse Control DisordersChapter 3. Pharmacological Treatment of Trauma and Stressor-Related DisordersChapter 4. Pharmacological Treatment of Sleep amp ndash Wake DisordersChapter 5. Pharmacological Treatment of Eating DisordersChapter . Pharmacological Treatment of Attention-Deficit/Hyperactivity DisorderChapter 7. Pharmacological Treatment of Autism Spectrum DisorderChapter 8. Pharmacological Treatment of Neurocognitive DisordersChapter 9. Pharmacological Treatment of Pain and Pain-Related DisordersChapter 2 . Pharmacological Treatment of Borderline Personality DisorderSection 2. Pharmacological Treatment of Substance Use Disorders and AddictionChapter 2 . General Introduction: Issues and Perspective on Medication Assisted TreatmentChapter 22. Pharmacological Treatment of Alcohol Use DisorderChapter 23. Pharmacological Treatment of Cannabis Use DisorderChapter 24. Pharmacological Treatment of Psychostimulant Use DisordersChapter 25. Pharmacological Treatment of Opioid Use DisordersChapter 2 . Pharmacological Treatment of Sedative and Anxiolytic Use DisordersChapter 27. Pharmacological Treatment of Tobacco Use DisorderChapter 28. Pharmacological Treatment of Behavioral AddictionsPart III. Psychopharmacology in Context: Issues Pertaining to Professional Training, Policy, and IndustryChapter 29. Professional Psychology in the Context of Psychopharmacology: Ethical Issues, Education, and TrainingChapter 3 . Psychologists and Integrated Behavioral Health Care Within the Framework of PsychopharmacologyChapter 3 . The Role of the Pharmaceutical Industry in the Treatment of Mental Health DisordersChapter 32. Nonpharmacological Neurotherapeutics: Principles and Methods of Brain Stimulation TherapyChapter 33. Future Directions in Theory, Research, Practice, and PolicyIndex

This comprehensive, 33-chapter desk reference, published by the highly reputable APA, captures the current research for emotional and behavioral conditions amp hellip . Highly recommended. (Choice)